Multiple sclerosis therapy

Abstract

Although still with the unclear etiology, multiple sclerosis (MS) is, according to the majority of researchers, autoimmune disease which affects people with the genetic predisposition. This is illness of the white mass of the brain and spinal cord which is causing damage to the myelin, but also to the degeneration of the axons, with the accompanying inflammatory reaction. Clinical course of the illness is characterized by wide distribution in time and space. It is more common among women than man (in some cases that ratio could be (3:1), among white than black, and it shows different geographical distribution. It is most frequent at the age from 20 to 40 years, but it is not uncommon in younger and older ages. Related to its still unknown ethiology the therapy in best case is imunomodulational or immunosuppressive, but in the majority of cases symptolmatological. After all of this question occurred: WHEN AND WHICH THERAPY WE SHOULD USE FOR THE PATIENTS?